EGFR and neoplasm: Furthermore, NLS-modified ADCs, such the epidermal growth factor receptor-positive tumor-targeting 111In-nimotuzumab-NLS, are infamous for their rapid plasma clearance and increased sequestration in normal tissues, which translate to reduced tumor accumulation [31,79].